NC NC AG Advisory Opinion (1984-03-13) 1984-03-13

Can a pregnant teenager in North Carolina give legal consent on her own for a sickle cell test as part of her prenatal care, or does she need a parent's permission first?

Short answer: Yes, she can give consent on her own. The 1984 AG concluded that a minor may give effective consent for sickle cell testing as part of pregnancy-related medical care, because pregnancy is one of the conditions for which G.S. 90-21.5 lets a minor consent, and laboratory testing falls within 'treatment' as defined by G.S. 90-21.2. A prior 1980 opinion that limited minor consent for genetic counseling did not control because that case was not pregnancy-related.
Currency note: this opinion is from 1984
Subsequent statutory amendments, court decisions, or later AG opinions may have changed the analysis. Treat this page as historical context, not current legal advice. Verify current law before relying on any specific rule, deadline, or remedy mentioned here.
Disclaimer: This is an official North Carolina Attorney General advisory opinion. AG opinions are persuasive authority but not binding precedent like a court ruling. This summary is for informational purposes only and is not legal advice. Consult a licensed North Carolina attorney for advice on your specific situation.
About this page: The plain-English summary, reader guidance, and Q&A below were written by Ezel based on the official AG opinion. The original opinion (linked at the bottom of this page) is the authoritative source for any reliance.

Plain-English summary

Margaret Dudley asked the AG whether a minor could give effective consent for sickle cell testing as part of her pregnancy-related care. The question came up because of a 1980 prior AG opinion to Dr. Sarah T. Morrow (49 N.C.A.G. 181) that limited minor consent in the genetic counseling context.

The 1984 AG distinguished the two situations and concluded that a pregnant minor can consent on her own. The reasoning had two pieces.

First, the 1980 opinion limited genetic counseling for minors because (i) genetic counseling was not one of the four categories of services for which G.S. 90-21.5 lets a minor give effective consent, and (ii) the definition of "treatment" in G.S. 90-21.2 did not include counseling. So an unaccompanied minor seeking genetic counseling on her own would risk a violation of common-law parent-child relationship principles, leaving the provider potentially vulnerable.

Second, the present case was different in both respects. Pregnancy is among the conditions for which G.S. 90-21.5 authorizes a minor to give consent. And sickle cell testing as a laboratory or diagnostic procedure falls within the term "treatment" as defined in G.S. 90-21.2.

Putting the two pieces together: a pregnant minor receiving prenatal care can consent to sickle cell testing as part of the medical management of her pregnancy. The provider does not need separate parental consent for the test if the test is being done as part of the pregnancy-related care the minor is already lawfully consenting to.

Currency note

This opinion was issued in 1984. Subsequent statutory amendments, court decisions, or later AG opinions may have changed the analysis. Treat this page as historical context, not current legal advice. Verify current law before relying on any specific rule, deadline, or remedy mentioned here. The North Carolina minor consent statutes have been amended since 1984, and the legal framework around genetic testing, prenatal screening, and adolescent reproductive health has continued to develop. The basic structure (specific categories of care for which minors may consent, with treatment broadly defined) likely remains intact, but specific statutory text should be checked against current law.

Historical context: what the AG concluded

The 1984 opinion does three things:

It preserves the 1980 prior opinion on its facts. The 1980 opinion was a careful reading of the genetic counseling situation. The AG did not overrule it. Genetic counseling for a minor outside a covered category still raises the common-law-parental-consent problem the 1980 opinion identified.

It distinguishes pregnancy-related care. Pregnancy is on the statutory list of conditions for which a minor may give effective consent. A pregnant minor receiving prenatal care is exercising her statutory authority directly; the analysis is not borrowed from the genetic counseling situation.

It reads "treatment" broadly to include diagnostic procedures. G.S. 90-21.2's definition of "treatment" includes "laboratory or other diagnostic procedures." That definition pulls sickle cell testing under the consent the minor is otherwise authorized to give for her pregnancy care. The provider does not have to break out testing and counseling and case management as separate consent transactions.

Background and statutory framework

North Carolina's minor consent statutes, codified at G.S. 90-21.2 through 90-21.6, allow minors to consent on their own to specific categories of medical care without parental involvement. The categories include pregnancy and pregnancy-related care, sexually transmitted disease care, substance abuse treatment, and emotional disturbance care.

The categories exist for public health reasons. Requiring parental consent in these specific areas would discourage minors from seeking needed care; the legislature judged the public health gain from removing the consent barrier worth the partial departure from the common-law rule that a minor cannot give legally binding consent to medical treatment.

The 1980 prior opinion took up a different problem: genetic counseling outside any of these public health categories. Genetic counseling for a minor with no pregnancy and no immediate health problem is closer to general health education than to specific medical care. The 1980 AG concluded the minor could not consent in that context, because none of the statutory categories applied and the broad definition of "treatment" did not reach counseling-only services.

The 1984 opinion brings the analysis back to the statutory text. If a minor is pregnant, she is in a covered category. If the care includes a laboratory diagnostic procedure, that procedure is "treatment" under the definition. The two together produce effective consent. The genetic counseling outside-the-categories problem the 1980 opinion identified does not arise.

Sickle cell anemia is a hereditary blood disorder that disproportionately affects African Americans. Routine sickle cell testing during pregnancy has been clinically standard since the 1970s, because pregnancy management for a sickle cell carrier or affected patient differs from management of a non-carrier patient. Removing a parental consent hurdle for this specific test makes it more likely that pregnant minors will receive standard prenatal care.

Common questions

Does this mean a pregnant minor can consent to any sickle cell test, or only one related to her pregnancy?

The opinion frames the answer in terms of pregnancy-related care. A sickle cell test ordered as part of the medical management of the pregnancy falls within the minor's consent. A standalone sickle cell test ordered for some other reason, with no pregnancy connection, might fall under a different analysis.

What about counseling about the test results?

The 1980 prior opinion's distinction between "treatment" and "counseling" still has bite. Sickle cell testing as a diagnostic procedure is treatment. Genetic counseling that follows the test, sitting down with the patient to explain implications for future pregnancies and family planning, is not treatment in the same sense and may need parental involvement when the minor is outside the pregnancy context.

Can the minor refuse parental notification entirely?

The minor consent statutes generally allow but do not require parental notification, leaving the provider with some discretion to inform parents in appropriate circumstances. The provider should follow the statute's framework and the specific facts. The opinion does not address parental notification beyond the consent question.

What if the parent objects after the fact?

The minor consent statutes give the minor effective consent for covered care. A parent's after-the-fact objection does not unwind the consent. The provider should have documentation that the care fell within a covered category.

How does this interact with confidentiality of test results?

The opinion addresses consent, not confidentiality. Test results are subject to whatever confidentiality framework applies (provider-patient privilege, medical record privacy law, public health reporting rules where applicable). Those frameworks may interact with minor-consent statutes in nuanced ways that the 1984 opinion did not reach.

Source

Citations

  • N.C.G.S. § 90-21.2
  • N.C.G.S. § 90-21.5
  • 49 N.C.A.G. 181 (May 21, 1980)

Original opinion text

Subject:

Requested By:

Conclusion:

A prior opinion of this Office to Dr. Sarah T. Morrow, dated May 21, 1980 (49 N.C.A.G. 181), concluded that "(to) provide genetic counseling to minors without (parental) consent would appear to be a violation of the common law principles governing the parent-child relationship and thus would leave the individual providing these services potentially vulnerable to the litigation." (Emphasis supplied) The conclusion was premised upon (i) the absence of genetic counseling from the four categories for which a minor may give effective consent under G.S. 90-21.5 and (ii) the failure of the definition in G.S. 90-21.2 to include counseling within the term "treatment."

In the present case, pregnancy is included within the conditions for which a minor may consent. Since sickle cell testing is necessary for the proper medical management of pregnancy, a minor may consent to such testing as part of the health services received for the pregnancy. Furthermore, in the present case, "laboratory or other diagnostic procedures," such as sickle cell testing, is included within the term "treatment" under G.S. 90-21.2.

Therefore, it is the opinion of this Office that G.S. 90-21.5 authorizes a minor to give effective consent for the performance of sickle cell testing as part of the medical treatment of the minor's pregnancy.

RUFUS L. EDMISTEN
Attorney General

Robert R. Reilly
Assistant Attorney General